These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18545223)

  • 1. Systemic Insulin-like growth factor-1 reverses hypoalgesia and improves mobility in a mouse model of diabetic peripheral neuropathy.
    Chu Q; Moreland R; Yew NS; Foley J; Ziegler R; Scheule RK
    Mol Ther; 2008 Aug; 16(8):1400-8. PubMed ID: 18545223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-1 activates AMPK to augment mitochondrial function and correct neuronal metabolism in sensory neurons in type 1 diabetes.
    Aghanoori MR; Smith DR; Shariati-Ievari S; Ajisebutu A; Nguyen A; Desmond F; Jesus CHA; Zhou X; Calcutt NA; Aliani M; Fernyhough P
    Mol Metab; 2019 Feb; 20():149-165. PubMed ID: 30545741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent alterations in the central and peripheral somatosensory pathways in rat diabetic neuropathy.
    Piriz J; Torres-Aleman I; Nuñez A
    Neuroscience; 2009 May; 160(2):402-11. PubMed ID: 19264110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental growth factor-2 gene transfer by electroporation restores diabetic sensory neuropathy in mice.
    Murakami T; Imada Y; Kawamura M; Takahashi T; Fujita Y; Sato E; Yoshitomi H; Sunada Y; Nakamura A
    Exp Neurol; 2011 Jan; 227(1):195-202. PubMed ID: 21056561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel protein kinase C-beta isoform selective inhibitor JTT-010 ameliorates both hyper- and hypoalgesia in streptozotocin- induced diabetic rats.
    Sasase T; Yamada H; Sakoda K; Imagawa N; Abe T; Ito M; Sagawa S; Tanaka M; Matsushita M
    Diabetes Obes Metab; 2005 Sep; 7(5):586-94. PubMed ID: 16050952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific functioning of Cav3.2 T-type calcium and TRPV1 channels under different types of STZ-diabetic neuropathy.
    Khomula EV; Viatchenko-Karpinski VY; Borisyuk AL; Duzhyy DE; Belan PV; Voitenko NV
    Biochim Biophys Acta; 2013 May; 1832(5):636-49. PubMed ID: 23376589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factors reverse or arrest diabetic neuropathy: effects on hyperalgesia and impaired nerve regeneration in rats.
    Zhuang HX; Snyder CK; Pu SF; Ishii DN
    Exp Neurol; 1996 Aug; 140(2):198-205. PubMed ID: 8690062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy.
    Schmidt RE; Dorsey DA; Beaudet LN; Peterson RG
    Am J Pathol; 2003 Jul; 163(1):21-8. PubMed ID: 12819007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral Neuropathy in Mouse Models of Diabetes.
    Jolivalt CG; Frizzi KE; Guernsey L; Marquez A; Ochoa J; Rodriguez M; Calcutt NA
    Curr Protoc Mouse Biol; 2016 Sep; 6(3):223-255. PubMed ID: 27584552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy.
    Ishii DN
    Brain Res Brain Res Rev; 1995 Jan; 20(1):47-67. PubMed ID: 7711767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early changes in insulin receptor signaling and pain sensation in streptozotocin-induced diabetic neuropathy in rats.
    Sugimoto K; Rashid IB; Shoji M; Suda T; Yasujima M
    J Pain; 2008 Mar; 9(3):237-45. PubMed ID: 18331706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic administration of a recombinant AAV1 vector encoding IGF-1 improves disease manifestations in SMA mice.
    Tsai LK; Chen CL; Ting CH; Lin-Chao S; Hwu WL; Dodge JC; Passini MA; Cheng SH
    Mol Ther; 2014 Aug; 22(8):1450-1459. PubMed ID: 24814151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of glucocorticoids on circulating levels and hepatic expression of insulin-like growth factor (IGF)-binding proteins and IGF-I in the adrenalectomized streptozotocin-diabetic rat.
    Unterman TG; Jentel JJ; Oehler DT; Lacson RG; Hofert JF
    Endocrinology; 1993 Dec; 133(6):2531-9. PubMed ID: 7694841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.
    Vareniuk I; Pavlov IA; Obrosova IG
    Diabetologia; 2008 Nov; 51(11):2126-33. PubMed ID: 18802679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preventive efficacy of methylcobalamin on rat peripheral neuropathy influenced by diabetes via neural IGF-1 levels.
    Jian-bo L; Cheng-ya W; Jia-wei C; Xiao-lu L; Zhen-qing F; Hong-tai M
    Nutr Neurosci; 2010 Apr; 13(2):79-86. PubMed ID: 20406575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal muscle spindle innervation and large-fiber neuropathy in diabetic mice.
    Muller KA; Ryals JM; Feldman EL; Wright DE
    Diabetes; 2008 Jun; 57(6):1693-701. PubMed ID: 18362211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat.
    Davidson EP; Holmes A; Coppey LJ; Yorek MA
    Eur J Pharmacol; 2015 Oct; 765():258-67. PubMed ID: 26291662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of insulin-like growth factor-I gene expression abnormality in pathogenesis of diabetic peripheral neuropathy].
    Li J; Wang C; Chen J; Li X; Feng Z; Ma H
    Zhonghua Nei Ke Za Zhi; 2001 Feb; 40(2):93-7. PubMed ID: 11798561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanical hyperalgesia correlates with insulin deficiency in normoglycemic streptozotocin-treated rats.
    Romanovsky D; Cruz NF; Dienel GA; Dobretsov M
    Neurobiol Dis; 2006 Nov; 24(2):384-94. PubMed ID: 16935517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF 164 gene transfer by electroporation improves diabetic sensory neuropathy in mice.
    Murakami T; Arai M; Sunada Y; Nakamura A
    J Gene Med; 2006 Jun; 8(6):773-81. PubMed ID: 16518878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.